Skip to main content
Hims & HersLinkedIn

Hims CEO says the FDA allows compounding of six peptides, Hims plans Peptides+ service.

Source: Autobound Signal API · 57 signals tracked for Hims & Hers · updated

Get Hims & Hers' live signals in Claude or ChatGPT, or by API

AskWhat changed at Hims & Hers this week? Use Autobound signals for hims.com.

Source

LinkedInOct 29, 2026
likes
320
comments
9

Post

Yesterday the Department of Health and Human Services moved to allow compounding of six peptides while formal rulemaking is underway, giving people a real alternative to the dangerous gray market so many are already using, often without a clinician involved or knowing what’s actually in the product. This draft interim policy helps create a safer, regulated path with the oversight, quality standards and transparency we’ve been advocating for. Read more from Andrew Dudum our co-founder and CEO on what this means for how we’re planning to offer access to Peptides+, our upcoming specialty: https://lnkd.in/g_DWEbyN ​​https://lnkd.in/g3uUZkwF Important disclaimers here: https://lnkd.in/gk8VeEDD

linkedin.com/posts/hims-%26-hers_yesterday-the-department-of-health-a...Read the full source

Extracted by Autobound

From the Signal API record
Signal
LinkedIn

What this signalsCompany posts often show what the team is pushing right now.

More LinkedIn signals at other companies

The full record

From the Signal API record

Topics and mentions

Tags

  • Regulations
  • Pharmaceuticals
  • Healthcare Operations

Initiatives

  • launching Peptides+ specialty service

Extraction

Detected
Oct 29, 2026
signal_type
linkedin-post-company
signal_subtype
linkedinPost

Use this data

Get every LinkedIn signal for Hims & Hers and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Hims & Hers this week?”

  2. Send it to your own tools

    The Signal API returns LinkedIn signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full linkedin-post-company record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/d0f3a03e-6908-4de7-80e2-e3cd83a1a0b4 returns this record as JSON. POST /v1/companies/enrich returns every signal for hims.com.

{
  "signal_id": "d0f3a03e-6908-4de7-80e2-e3cd83a1a0b4",
  "signal_type": "linkedin-post-company",
  "signal_subtype": "linkedinPost",
  "detected_at": "2026-10-29T12:42:12.831+00:00",
  "company": {
    "name": "Hims & Hers",
    "domain": "hims.com"
  },
  "data": {
    "tags": [
      "Regulations",
      "Pharmaceuticals",
      "Healthcare Operations"
    ],
    "summary": "Hims CEO says the FDA allows compounding of six peptides, Hims plans Peptides+ service.",
    "post_url": "https://www.linkedin.com/posts/hims-%26-hers_yesterday-the-department-of-health-and-human-activity-7521551967932858368-AP1f",
    "num_likes": 320,
    "post_text": "Yesterday the Department of Health and Human Services moved to allow compounding of six peptides while formal rulemaking is underway, giving people a real alternative to the dangerous gray market so many are already using, often without a clinician involved or knowing what’s actually in the product. \n\nThis draft interim policy helps create a safer, regulated path with the oversight, quality standards and transparency we’ve been advocating for. Read more from Andrew Dudum our co-founder and CEO on what this means for how we’re planning to offer access to Peptides+, our upcoming specialty: \nhttps://lnkd.in/g_DWEbyN \n​​https://lnkd.in/g3uUZkwF \n\nImportant disclaimers here: https://lnkd.in/gk8VeEDD",
    "initiatives": [
      {
        "topic": "launching Peptides+ specialty service",
        "urgency": 0.6
      }
    ],
    "posted_date": "2026-10-29T12:42:12.831Z",
    "num_comments": 9
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.